Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Narcolepsy

Recruiting

Investigational

Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Investigational

France

Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Registered drug

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Mirikizumab

Contact Research Centre

Alcoholism

Recruiting

Registered drug

Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Oxybate

Contact Research Centre

Hepatic fibrosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Clazakizumab

Contact Research Centre

Hepatic cirrhosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

France

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

France

Participants:18–64 years · 65+ years
Substances:Dazucorilant

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

France

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational

France

Participants:18–64 years · 65+ years
Substances:LY3537031

Contact Research Centre

Find therapies in clinical trials near you – page 4

1 090 trials match your criteria

Narcolepsy

Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Systemic lupus erythematosus

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Neoplasm malignant

Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

Crohn's disease

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

Alcoholism

Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

Hepatic fibrosis+2

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Neoplasm malignant

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Arteriosclerosis

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Hepatic cirrhosis+2

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Amyotrophic lateral sclerosis

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Chronic obstructive pulmonary disease

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.